Pneumonia

Written by Dr. Imogen Walker (F1), Dr Alex Tom (paediatric trainee) and Dr Sara Kussad, Paediatric Respiratory Fellow

Last updated 9th May 2026
13 Revisions

Pneumonia - Podcast Version

TeachMePaediatrics

0:00 / 0:00

Introduction 

Aside from the neonatal period, lower respiratory tract infections are the most common cause of death in children under 5. The term lower respiratory tract infection (LRTI) refers to infection below the level of the larynx, including the trachea, bronchi, bronchioles and alveoli. LRTI is an umbrella term for several conditions such as pneumonia, acute bronchitis and bronchiolitis.

In this article, we will focus on pneumonia and the pathophysiology, clinical features, management and complications of this disease in childhood.

Epidemiology

Although incidence of pneumonia peaks at the extremes of age, it is still high during childhood, with around 3% of children over the age of 12 months having a LRTI each year1. Pneumonia is the commonest cause of mortality and hospital admissions in children2.

Pathophysiology

Pneumonia can be caused by both viruses and bacteria. The causative organism often goes undetected; however, the age of the child, alongside any co-morbidities they may have, can make certain pathogens more likely.

Newborn Group B streptococcus, Gram-negative enterococci and bacilli
Infants and young children Respiratory Syncytial Virus (RSV), S. Pneumoniae, H. Influenzae, S. Aureus
Children > 5 years old Streptococcus Pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumoniae
Immunocompromised Pneumocystis Jirovecii
Cystic Fibrosis Staphylococcus aureus and pseudomonas aeruginosa

Mycobacterium tuberculosis should always be considered as a causative organism1.

Pathogens enter the lower respiratory tract via inhalation, aspiration, invasion of the respiratory epithelium or haematogenous spread3. If anatomical and immunological “barriers to infection” are overcome, the presence of pathogens in the lung can cause localised inflammation. This results in damage to alveoli and epithelial cells. Subsequently, inflammatory cells cluster around the infected area. This exudative mechanism impairs oxygenation3.

Comparison of normal alveoli to an alveoli during pneumonia

Risk Factors

  • Younger in age
  • Malnourishment
  • Immunocompromised
  • Exposure to cigarette smoke
  • Air pollution4
  • Ill contacts
  • Immunisations not up to date
  • Recent travel 1,4

Clinical Features

History1,4

  • High temperatures
  • Shortness of breath
  • Cough
  • Post-tussive vomiting
  • Lethargy
  • Aches and pains, specifically around the abdomen, chest and neck, due to the effects of the pleural effusion
  • Reduced feeding

Examination

  • Tachypnoea5 – this is the most sensitive clinical sign1
    • >60 for 0-5 months
    • >50 for 6-12 months
    • >40 for over >12 months
  • Signs of cyanosis
  • Signs of increased work of breathing
    • Nasal flaring
    • Tracheal tug
    • Intercostal and subcostal recession
    • Abdominal breathing
  • Auscultation Findings
    • End inspiratory crackles
    • Bronchial breathing
    • Absent breath sounds
    • Decreased breath sounds
  • Percussion Findings
    • Dullness to percussion due to consolidation
    • Stony dullness due to effusion or empyema

Differential Diagnosis

  • Bronchiolitis
  • Acute bronchitis
  • Asthma
  • Cystic fibrosis
  • Congenital heart disease

Investigations

The SPUR acronym is a useful aid to determine if investigations are necessary 8

  • Severe
  • Persistent
  • Unusual
  • Recurrent

Laboratory6

  • Nasopharyngeal secretions +/- swabs for viral PCR
  • Sputum for microscopy and culture
  • Serology for Respiratory viruses, chlamydia and mycoplasma
  • Pleural fluid sent for microscopy and culture
  • Investigate for TB and HIV in areas with high disease prevalence 8
  • Blood investigations – Full blood count, Inflammatory markers like CRP.

Imaging6

  • Chest X-ray
  • Ultrasound scan can be considered if signs of complications, such as pleural effusion or empyema.

Management

Children with pneumonia benefit from early investigations (if necessary) and management to prevent future acute and chronic complications of pneumonia 2.

Immunisation

  • Pneumococcal vaccine for children in at-risk groups 7
  • Haemophilus influenzae type B 8

Initial management

NICE CKS – 999 or hospital admission if any of the below 4,5

  • Oxygen saturations consistently below 92% on air
  • Respiratory rate >60
  • Signs of cyanosis
  • The child is unarousable or struggles to stay awake
  • A temperature of 38 degrees or higher in a child less than 3 months old
  • Signs of a clinically unwell child
  • Apnoea

NICE CKS consider hospital admission if 5

  • Increased respiratory rate
  • Signs of cyanosis
  • Increased effort breathing (such as grunting, nasal flaring, marked recession)
  • Fluid intake reduced to 50-75% normal or clinical signs of dehydration, such as fewer wet nappies
  • Less responsive or difficult to rouse
  • Persistent worsening of fever, or if it does not settle within 48 hours, or initiation of antibiotic treatment

If the child does not require hospital admission 5

  • Oral antibiotics (may vary depending on local guidelines)
    • 1st line: 5-day course of amoxicillin
    • If no response to amoxicillin, add on a macrolide such as clarithromycin
    • Association with influenza – co-amoxiclav
  • If the child is distressed, use paracetamol (note: not indicated solely for fever)
  • Regular fluids
  • Check on the child regularly
  • Safety netting advice to the parents.

Management in hospital 6

  • IV antibiotics, initially broad-spectrum and then rationalised based on microbiology
  • IV fluids if the child is unable to manage oral intake (ensure urea and electrolytes are monitored daily)
  • Chest physiotherapy
  • Management of complications will be based on the clinical picture, blood markers and imaging.
    • Children with complications such as a para-pneumonic effusion or an empyema may benefit from insertion of a small-bore chest drain under ultrasound, flushed regularly with a fibrinolytic 6.
    • If the patient develops a lung abscess, they may require surgical drainage 9. In severe cases, a VATS procedure or thoracotomy may be indicated 6.

Follow up – the 4 C’s of follow up 8

  • Follow up Chest X-ray to ensure resolution 4-6 weeks after the initial episode if
    • Continued symptoms
    • Collapse
    • Consolidation
    • Complications (abscess / empyema / effusion)

Complications

  • Para-pneumonic effusion is present in a third of children and resolves with the resolution of the pneumonia1
  • Pleural empyema is when the pleural fluid becomes infected. Fibrin strands can form within the empyema, causing septations.
  • Intrapulmonary abscess
  • Post infectious bronchiectasis8 – Common in children with recurrent or severe infection.

References

(1) Chapter 17 Respiratory Disorders: Lower Respiratory Tract Infections. In Lissauer T, Carroll W. Illustrated Textbook of Paediatrics. 6e. Poland: Elsevier; 2022.  
(2) Early childhood lower respiratory tract infection and premature adult death from respiratory disease in Great Britain: a national birth cohort study. Allinson, James Peter et al. The Lancet, Volume 401, Issue 10383, 1183 – 1193

 

(3) Ebeledike C, Ahmad T. “Pediatric Pneumonia”. 2023 Jan 16. In: StatPearls. Treasure Island, (FL): StatPearls Publishing. Available at: https://www.ncbi.nlm.nih.gov/books/NBK536940/
(4) Asthma and Lung UK, “How to spot respiratory tract infections in children”, April 2022. Online. [Online]. Available at How to spot respiratory tract infections in children | Asthma + Lung UK . [Accessed December 2024].
(5) National Institute for Health and Care Excellence, “Scenario: Community-acquired pneumonia”, August 2025. [Online]. Available at Scenario: Community-acquired pneumonia | Management | Cough – acute with chest signs in children | CKS | NICE.[Accessed December 2024].

 

(6) Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax BMJ journals. 2011 Oct; 66 (supplement 2) ii1 – ii23. doi:10.1136/thoraxjnl-2011-200598
(7) National Institute for Health and Care Excellence, “pneumococcal vaccine”, ? Date, Available at: https://bnf.nice.org.uk/treatment-summaries/pneumococcal-vaccine/#children-with-unknown-or-incomplete-vaccination-histories. Accessed on 07/01/2025.

 

(8) Dangor Z, Verwey C, Lala SG, Mabaso T, Mopeli K, Parris D, Gray DM, Chang AB and Zar HJ (2021) Lower Respiratory Tract Infection in Children: When Are Further Investigations Warranted? Front. Pediatr. 9:708100. doi: 10.3389/fped.2021.708100
(9) Chirteş IR, Mărginean CO, Gozar H, Georgescu AM, Meliţ LE. Lung Abscess Remains a Life-Threatening Condition in Pediatrics – A Case Report. J Crit Care Med (Targu Mures). 2017 Aug 19;3(3):123-127. doi: 10.1515/jccm-2017-0023.

Do you think you’re ready? Take the quiz below

Pro Feature - Quiz
Pneumonia

Question 1 of 3

Submitting...
Rate question:
You scored
0%
Skipped: 0/3

1000+ More Questions Available

Upgrade to TeachMePaediatrics Pro

Challenge yourself with over 1000 multiple-choice questions to reinforce learning

Learn More